Teva Launches “Teva Rise” to Accelerate Global Pharma Innovation Through AI, Industry 4.0 and Digital Health

Teva Pharmaceutical Industries has launched Teva Rise, a global open innovation platform aimed at advancing AI, Industry 4.0 smart manufacturing, digital health, and biotech solutions by partnering with startups and technology companies. The initiative aligns with Teva’s Pivot to Growth strategy and seeks to co-develop solutions that address major pharmaceutical challenges while driving patient-centric impact and enterprise-wide transformation.

Transforming Drug Development and Manufacturing

The launch comes at a time when AI-driven drug development and digital transformation are accelerating across the industry. Through Teva Rise, innovators gain access to real-world validation opportunities across Teva’s global ecosystem, enabling rapid scaling of high-impact technologies. The platform aims to strengthen Teva’s shift toward becoming a leading biopharmaceutical company with advanced digital and manufacturing capabilities.

Seven Innovation Challenges Announced

Teva is inviting startups to propose solutions across seven priority challenge areas, including human-predictive platforms for biologics testing, AI-powered clinical protocol design, digital innovations for long-acting injectables, tender value optimization, predictive maintenance, AI-based product quality forecasting, and intelligent resource allocation for supply chain resilience. These challenges span R&D, manufacturing, supply chain, and commercial operations.